A global company with a community promise
At BioCryst, advancing novel therapeutics for patients with complement-mediated and rare diseases is our purpose. With our global presence, the work we do helps patients take part in the everyday activities they enjoy, wherever they live. We focus on breaking new ground by blending pioneering technology and science with a more people-focused approach. We deliver medicines that have the potential to improve the lives of people living with complement-mediated and rare diseases.
Our commitment to improving the lives of people living with complement-mediated and rare diseases starts with listening to and understanding the needs of patients and their loved ones. It’s about building trust and working collaboratively with advocacy organizations. It’s about getting the right treatments into the hands of patients who need them most. This is the reason we’re here.
Our focus is on breaking new ground in challenging rare disease categories. Using a novel, structure-guided approach, we blend traditional biology and medicinal chemistry with an array of advanced technologies to deliver the convenience of less intense or invasive methods of drug delivery to patients.
Founded in 1986 out of the labs of the University of Alabama at Birmingham, BioCryst is one of the oldest independent global biotechnology companies in operation. We have been guided by our commitment to never settle for ordinary in our quest to deliver novel medicines, and we continue to grow our presence around the globe to make “extraordinary” a reality for as many people as possible.